The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 19, 2024

Filed:

Oct. 13, 2020
Applicants:

The Broad Institute, Inc., Cambridge, MA (US);

Massachusetts Institute of Technology, Cambridge, MA (US);

Inventors:

Paul Blainey, Cambridge, MA (US);

Anthony Kulesa, Cambridge, MA (US);

Kan Xiong, Cambridge, MA (US);

Assignees:

The Broad Institute, Inc., Cambridge, MA (US);

Massachusetts Institute of Technology, Cambridge, MA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/569 (2006.01); A61K 31/4375 (2006.01); A61K 47/54 (2017.01); A61K 47/64 (2017.01); C07K 14/00 (2006.01); C07K 14/39 (2006.01); C07K 14/47 (2006.01); C12N 15/67 (2006.01); C12Q 1/6848 (2018.01); C12Q 1/686 (2018.01);
U.S. Cl.
CPC ...
G01N 33/56966 (2013.01); A61K 31/4375 (2013.01); A61K 47/549 (2017.08); A61K 47/64 (2017.08); A61K 47/645 (2017.08); C07K 14/00 (2013.01); C07K 14/39 (2013.01); C07K 14/4705 (2013.01); C12N 15/67 (2013.01); C12Q 1/6848 (2013.01); C12Q 1/686 (2013.01); C07K 2319/01 (2013.01); C07K 2319/80 (2013.01); G01N 2800/00 (2013.01);
Abstract

The present invention relates to compositions which may comprise a non-naturally occurring or engineered artificial transcription factor, wherein the transcription factor may comprise a sequence specific DNA binding domain, a sliding domain, and one or more linkers, wherein the DNA binding domain and the sliding domain are operably connected by the one or more linkers, and uses thereof. Methods involving the use of a non-naturally occurring or engineered artificial transcription factors and pharmaceutical compositions, methods for treating cancer, a degenerative disease, a genetic disease or an infectious disease as well as diagnostic methods are also contemplated by the present invention.


Find Patent Forward Citations

Loading…